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Despite the availability of effective modern 
contraceptive methods in Bangladesh, the 
number of unsafe menstrual regulations  
is increasing each year, resulting in 
increased risk of maternal morbidity.  
Menstrual regulation (MR) is a medical method of 
safely establishing non-pregnancy after a missed 
period. In Bangladesh, MR is typically conducted 
using manual vacuum aspiration (MVA). In 2010, 
approximately 653,000 MRs were performed in 
Bangladesh.  
However, MR using MVA carries both health and 
social risks: 
 Stigma and the fear of their situation being 
disclosed to their community often lead women to 
turn to illegal measures for abortions that are 
ineffective, harmful, and life-threatening.  
 Studies suggest that unsafe MVA performed by 
unskilled providers in unhygienic conditions 
results in over one-third of women suffering post-
MVA complications.  
 Statistics from selected NGO facilities that 
provide postabortion care services indicate that 
25–48% of women who visited these facilities 
requested treatment for post-MVA 
complications (Causes included poor service 
quality, lack of infection control, and unskilled 
individuals providing unsafe MVA). 
 
Why is Menstrual Regulation through 
Medication important? 
Menstrual Regulation with Medication (MRM) is a 
non-invasive, safe alternative to MVA that is approved 
in Bangladesh but not yet widely available. By 
increasing access to this simple and safe MR option, 
women’s morbidity due to MR in Bangladesh could be 
significantly decreased. 
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CONCLUSIONS  
 It is feasible and safe to 
introduce Menstrual 
Regulation with Medication in 
Bangladesh. 
 Women receiving MRM were 
satisfied with their quality of 
care. 
RECOMMENDATIONS 
The Ministry of Health and 
Family Welfare, along with its 
partners, must: 
 In preparation for introducing 
MRM nationwide, plan a 
scale-up strategy for phasing 
in services. 
 Implement services first in 
urban health facilities such as 
Maternal and Child Welfare 
Centres (MCWCs) and 
gradually expand to rural 
areas. 
 Simultaneously, implement a 
comprehensive training 
program to train all public 
sector MR service providers. 
 Provide adequate supervision 
so as to ensure the quality of 
services. 
 Revise and update the 
management information 
system to include MRM 
information.  
 Ensure that the requisite 
medications are routinely 
supplied to all facilities 
providing MRM services. 
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About this study  
The Population Council and Marie Stopes 
Bangladesh, in collaboration with the Directorate 
General of Family Planning and with funding from the 
World Health Organisation, tested the feasibility of 
introducing MRM in Bangladesh and assessed the 
acceptability of providing MRM using the combination 
drug regimen Mifepristone and Misoprostol in urban 
and rural public health facilities.  
 
An 18-month operations research study was conducted 
from January 2012 to June 2013. Health facilities were 
selected with high numbers of MR clients and available 
trained service providers. All women who visited the 13 
health facilities for MR services between October 2012 
and May 2013 were invited to participate in the study. 
 
All women were counseled by trained service providers 
about the advantages, disadvantages, and side effects of 
MR and given a choice between MVA and MRM to 
regulate menstruation. Clients selecting MRM had the 
option of taking the second dose—Misoprostol 800mcg—
at the health facility or at home after 24–48 hours.  
 
 Of the 2,976 women who visited the health facilities 
seeking MR services 63 percent (1,882) selected 
MRM services. 
 Using simple random sampling, information was 
collected from 836 MRM acceptors and 44 service 
providers to assess the feasibility and outcomes of 
the procedure.  
 Women who self-administered the second dose were 
educated on the correct technique for taking the drug, 
possible side effects, and were given clear 
instructions to return to the facility or seek immediate 
medical attention from the call center if they 
experienced heavy or prolonged vaginal bleeding, 
sever cramping, fever, chills or malaise lasting more 
than six hours, any abnormal vaginal discharge, 
severe abdominal pain, or nausea. 
 Women were asked to return to the facility within   
10–14 days after taking the second dose for a 
bimanual pelvic examination to confirm completeness 
of the MRM procedure. 
 
 
 
 
Results  
 Nearly all providers determined the last menstrual 
period and 70 percent took a menstrual history. The 
overall quality of services provided at these health 
facilities was high. 
 Almost all MRM acceptors (97 percent) reported that 
they would suggest MRM to their friends and relatives; 
95 percent would refer a friend to the same facility. 
 The vast majority (92%) of women returned to the 
facility for the examination to confirm procedure 
completion. 
 One in five clients experienced a side effect 
(commonly nausea) after taking Mifepristone (first 
dose), although less than half of these women 
required medication or further treatment for the side 
effect.  
 Of the 71 women (5%) who experienced incomplete 
MRM, 59 received MVA and 12 were referred for 
dilation and curettage (D&C) services to complete the 
procedure. 
 The most frequently discussed contraceptive methods 
during follow-up visits were oral contraceptive pills 
(77%) followed by IUDs and condoms. Findings 
suggest that 69 percent of MRM clients accepted oral 
pills and 12 percent did not accept any form 
contraception while 19 percent selected other short-
acting methods. 
 
Conclusions 
This study demonstrates that is feasible and safe to 
introduce MRM in Bangladesh in rural and urban public 
health facilities. Given the choice, almost two-thirds of 
women preferred MRM to MVA and women receiving 
MRM reported being satisfied or very satisfied with their 
quality of care. It is recommended that the Ministry of 
Health and Family Welfare (MOHFW) and its partners 
work together to train providers and to procure the medical 
commodities to introduce MRM as an option for menstrual 
regulation in health facilities nationwide. 
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